Table 2 |
||||||||||||||||
|
Nucleotide diversity and neutrality tests for the analysed gene regions |
||||||||||||||||
|
Gene |
La |
Pb |
Sc |
θWd |
πe |
Tajima's D |
Fu & Li's D* |
Fu & Li's F* |
||||||||
|
|
||||||||||||||||
|
value |
rankf |
value |
rankf |
value |
rankf |
pg |
value |
rankf |
pg |
value |
rankf |
pg |
||||
|
|
|
|
|
|
||||||||||||
|
ZSCAN23 |
3.3 |
CEU |
7 |
4.96 |
0.44 |
6.52 |
0.66 |
0.87 |
0.78 |
0.20 |
0.51 |
0.72 |
0.34 |
0.73 |
0.74 |
0.25 |
|
VARS2 |
3.2 |
CEU |
10 |
7.30 |
0.69 |
10.78 |
0.86 |
1.43 |
0.89 |
0.09 |
0.24 |
0.65 |
0.40 |
0.73 |
0.74 |
0.25 |
|
HLA-DMB |
3.1 |
CEU |
14 |
10.60 |
0.91 |
12.12 |
0.89 |
0.45 |
0.66 |
0.30 |
-0.28 |
0.47 |
0.60 |
-0.050 |
0.54 |
0.51 |
|
PTPN22 |
3.5 |
CEU |
7 |
4.70 |
0.44 |
4.57 |
0.41 |
-0.077 |
0.51 |
0.49 |
-0.98 |
0.23 |
0.80 |
-0.81 |
0.31 |
0.75 |
|
BAT3 |
2.0 |
CEU |
3 |
3.47 |
0.21 |
3.14 |
0.27 |
-0.20 |
0.47 |
0.57 |
-0.35 |
0.46 |
0.64 |
-0.36 |
0.44 |
0.62 |
|
C6orf47 |
2.0 |
CEU |
3 |
3.59 |
0.21 |
5.21 |
0.48 |
0.98 |
0.81 |
0.18 |
0.92 |
0.85 |
0.19 |
1.09 |
0.84 |
0.13 |
|
IL10 |
2.3 |
CEU |
3 |
2.97 |
0.15 |
5.95 |
0.55 |
2.12 |
0.97 |
0.01 |
0.90 |
0.84 |
0.16 |
1.47 |
0.94 |
0.04 |
|
CDSN/ |
4.5 |
CEU |
59 |
30.80 |
>0.99 |
49.42 |
>0.99 |
2.17 |
0.97 |
0.01 |
1.40 |
0.95 |
0.03 |
1.98 |
0.97 |
0.01 |
|
PSORSC1 |
||||||||||||||||
|
YRI |
63 |
32.88 |
>0.99 |
46.20 |
>0.99 |
1.46 |
0.99 |
0.01 |
1.44 |
>0.99 |
<0.01 |
1.72 |
>0.99 |
<0.01 |
||
|
EAS |
64 |
33.41 |
>0.99 |
47.50 |
>0.99 |
1.52 |
0.91 |
0.08 |
1.45 |
0.98 |
001 |
1.75 |
0.98 |
0.02 |
||
|
TRIM40/ |
9.1 |
CEU |
68 |
17.51 |
0.98 |
26.13 |
0.99 |
1.78 |
0.96 |
0.03 |
1.61 |
0.98 |
<0.01 |
1.98 |
0.97 |
<0.01 |
|
TRIM10 |
||||||||||||||||
|
YRI |
64 |
16.48 |
0.96 |
15.74 |
0.94 |
-0.16 |
0.64 |
0.22 |
1.07 |
0.97 |
<0.01 |
0.76 |
0.93 |
0.02 |
||
|
EAS |
79 |
20.34 |
0.99 |
19.33 |
0.98 |
-0.18 |
0.46 |
0.31 |
-0.20 |
0.46 |
0.68 |
-0.23 |
0.45 |
0.71 |
||
|
BTNL2 |
3.8 |
CEU |
53 |
33.04 |
>0.99 |
39.75 |
0.99 |
-0.33 |
0.42 |
0.36 |
1.32 |
0.93 |
0.03 |
0.88 |
0.78 |
0.15 |
|
YRI |
63 |
39.28 |
>0.99 |
30.01 |
>0.99 |
0.043 |
0.71 |
0.18 |
0.67 |
0.89 |
0.06 |
0.53 |
0.86 |
0.07 |
||
|
EAS |
94 |
58.60 |
>0.99 |
47.38 |
>0.99 |
-0.70 |
0.31 |
0.21 |
0.95 |
0.88 |
0.13 |
0.43 |
0.69 |
0.35 |
||
|
TAP2 |
4.4 |
CEU |
33 |
17.56 |
0.98 |
29.07 |
0.99 |
2.27 |
0.98 |
0.01 |
1.59 |
0.98 |
0.01 |
2.16 |
0.98 |
<0.01 |
|
YRI |
54 |
28.73 |
>0.99 |
34.55 |
>0.99 |
0.73 |
0.94 |
0.05 |
1.63 |
>0.99 |
<0.01 |
1.56 |
0.99 |
<0.01 |
||
|
EAS |
41 |
21.81 |
0.99 |
32.88 |
>0.99 |
1.79 |
0.97 |
0.04 |
1.30 |
0.96 |
0.04 |
1.74 |
0.98 |
0.02 |
||
|
TAP2-ctr |
2.6 |
CEU |
12 |
10.71 |
0.91 |
12.18 |
0.89 |
0.42 |
0.65 |
0.32 |
0.46 |
0.70 |
0.29 |
0.52 |
0.69 |
0.18 |
|
BTNL2-ctr |
2.0 |
CEU |
15 |
17.47 |
0.98 |
16.73 |
0.96 |
-0.14 |
0.50 |
0.54 |
1.56 |
0.97 |
0.01 |
1.18 |
0.90 |
0.09 |
|
|
||||||||||||||||
|
a length of analyzed sequenced region (kb); b sampled population (for each population 40 chromosomes were resequenced); c number of segregating sites; d Watterson's theta estimation per site (×10-4); e nucleotide diversity per site (×10-4); f percentile rank relative to a distribution of 238 5kb segments from NIEHS genes; g p value applying demographic coalescent simulations. |
||||||||||||||||
|
Cagliani et al. BMC Evolutionary Biology 2011 11:171 doi:10.1186/1471-2148-11-171 |
||||||||||||||||
